Si-Yang Li

1.8k total citations
27 papers, 1.2k citations indexed

About

Si-Yang Li is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Si-Yang Li has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 23 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in Si-Yang Li's work include Tuberculosis Research and Epidemiology (25 papers), Mycobacterium research and diagnosis (18 papers) and Cancer therapeutics and mechanisms (7 papers). Si-Yang Li is often cited by papers focused on Tuberculosis Research and Epidemiology (25 papers), Mycobacterium research and diagnosis (18 papers) and Cancer therapeutics and mechanisms (7 papers). Si-Yang Li collaborates with scholars based in United States, China and South Africa. Si-Yang Li's co-authors include Eric L. Nuermberger, Paul J. Converse, Deepak V. Almeida, Sandeep Tyagi, J Grosset, Khisimuzi Mdluli, Rokeya Tasneen, Koen Andries, Tianyu Zhang and Kathy N. Williams and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Si-Yang Li

27 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Si-Yang Li United States	18	979	819	416	228	140	27	1.2k
Aurélie Chauffour France	18	895 0.9×	804 1.0×	335 0.8×	293 1.3×	125 0.9×	35	1.1k
Vanessa Mathys Belgium	21	900 0.9×	742 0.9×	466 1.1×	236 1.0×	146 1.0×	52	1.3k
Yaoju Tan China	21	934 1.0×	761 0.9×	445 1.1×	243 1.1×	110 0.8×	61	1.2k
Jansy P. Sarathy United States	20	1.2k 1.2×	810 1.0×	541 1.3×	232 1.0×	200 1.4×	38	1.5k
Jurriaan E.M. de Steenwinkel Netherlands	18	610 0.6×	493 0.6×	250 0.6×	151 0.7×	150 1.1×	49	959
Keira A. Cohen United States	17	561 0.6×	511 0.6×	283 0.7×	119 0.5×	145 1.0×	20	924
Sang Nae Cho South Korea	15	1.1k 1.1×	828 1.0×	405 1.0×	359 1.6×	135 1.0×	28	1.4k
Mridula Bose India	20	936 1.0×	780 1.0×	419 1.0×	341 1.5×	136 1.0×	59	1.4k
Taeksun Song South Korea	17	843 0.9×	699 0.9×	505 1.2×	219 1.0×	120 0.9×	34	1.3k
Rokeya Tasneen United States	20	1.4k 1.5×	998 1.2×	616 1.5×	367 1.6×	189 1.4×	35	1.7k

Countries citing papers authored by Si-Yang Li

Since Specialization

Citations

This map shows the geographic impact of Si-Yang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Si-Yang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Si-Yang Li more than expected).

Fields of papers citing papers by Si-Yang Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Si-Yang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Si-Yang Li. The network helps show where Si-Yang Li may publish in the future.

Co-authorship network of co-authors of Si-Yang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Si-Yang Li. A scholar is included among the top collaborators of Si-Yang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Si-Yang Li. Si-Yang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Encinas, Lourdes, Si-Yang Li, Rokeya Tasneen, et al.. (2024). Contribution of direct InhA inhibitors to novel drug regimens in a mouse model of tuberculosis. Antimicrobial Agents and Chemotherapy. 68(11). e0035724–e0035724. 3 indexed citations

Tyagi, Sandeep, Andrew Garcia, Deepak V. Almeida, et al.. (2024). Contribution of telacebec to novel drug regimens in a murine tuberculosis model. Antimicrobial Agents and Chemotherapy. 69(1). e0096224–e0096224. 1 indexed citations

Yu, Tingting, Si-Yang Li, Sarah Dugan, et al.. (2021). Deletion at an 1q24 locus reveals a critical role of long noncoding RNA DNM3OS in skeletal development. Cell & Bioscience. 11(1). 5 indexed citations

Ammerman, Nicole C., et al.. (2020). Differential In Vitro Activities of Individual Drugs and Bedaquiline-Rifabutin Combinations against Actively Multiplying and Nutrient-Starved Mycobacterium abscessus. Antimicrobial Agents and Chemotherapy. 65(2). 11 indexed citations

Rifat, Dalin, Si-Yang Li, Thomas R. Ioerger, et al.. (2020). Mutations in fbiD ( Rv2983 ) as a Novel Determinant of Resistance to Pretomanid and Delamanid in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 65(1). 56 indexed citations

Xu, Jian, Si-Yang Li, Deepak V. Almeida, et al.. (2019). Contribution of Pretomanid to Novel Regimens Containing Bedaquiline with either Linezolid or Moxifloxacin and Pyrazinamide in Murine Models of Tuberculosis. Antimicrobial Agents and Chemotherapy. 63(5). 71 indexed citations

Omansen, Till F., Deepak V. Almeida, Paul J. Converse, et al.. (2018). High-Dose Rifamycins Enable Shorter Oral Treatment in a Murine Model of Mycobacterium ulcerans Disease. Antimicrobial Agents and Chemotherapy. 63(2). 13 indexed citations

Converse, Paul J., Deepak V. Almeida, Rokeya Tasneen, et al.. (2018). Shorter-course treatment for Mycobacterium ulcerans disease with high-dose rifamycins and clofazimine in a mouse model of Buruli ulcer. PLoS neglected tropical diseases. 12(8). e0006728–e0006728. 20 indexed citations

Almeida, Deepak V., Till F. Omansen, Si-Yang Li, et al.. (2018). Oxazolidinones Can Replace Clarithromycin in Combination with Rifampin in a Mouse Model of Buruli Ulcer. Antimicrobial Agents and Chemotherapy. 63(3). 6 indexed citations

10.

Xu, Jian, Rokeya Tasneen, Charles A. Peloquin, et al.. (2017). Verapamil Increases the Bioavailability and Efficacy of Bedaquiline but Not Clofazimine in a Murine Model of Tuberculosis. Antimicrobial Agents and Chemotherapy. 62(1). 36 indexed citations

11.

Tyagi, Sandeep, Nicole C. Ammerman, Si-Yang Li, et al.. (2015). Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis. Proceedings of the National Academy of Sciences. 112(3). 869–874. 91 indexed citations

12.

Li, Si-Yang, Scott M. Irwin, Paul J. Converse, et al.. (2015). Evaluation of Moxifloxacin-Containing Regimens in Pathologically Distinct Murine Tuberculosis Models. Antimicrobial Agents and Chemotherapy. 59(7). 4026–4030. 33 indexed citations

13.

Converse, Paul J., Sandeep Tyagi, Yalan Xing, et al.. (2015). Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease. PLoS neglected tropical diseases. 9(6). e0003823–e0003823. 17 indexed citations

14.

Converse, Paul J., Yalan Xing, Ki Hyun Kim, et al.. (2014). Accelerated Detection of Mycolactone Production and Response to Antibiotic Treatment in a Mouse Model of Mycobacterium ulcerans Disease. PLoS neglected tropical diseases. 8(1). e2618–e2618. 28 indexed citations

15.

Grosset, J, Sandeep Tyagi, Deepak V. Almeida, et al.. (2013). Assessment of Clofazimine Activity in a Second-Line Regimen for Tuberculosis in Mice. American Journal of Respiratory and Critical Care Medicine. 188(5). 608–612. 92 indexed citations

16.

Almeida, Deepak V., Paul J. Converse, Si-Yang Li, et al.. (2013). Bactericidal Activity Does Not Predict Sterilizing Activity: The Case of Rifapentine in the Murine Model of Mycobacterium ulcerans Disease. PLoS neglected tropical diseases. 7(2). e2085–e2085. 12 indexed citations

17.

Zhang, Tianyu, Si-Yang Li, Paul J. Converse, J Grosset, & Eric L. Nuermberger. (2013). Rapid, Serial, Non-invasive Assessment of Drug Efficacy in Mice with Autoluminescent Mycobacterium ulcerans Infection. PLoS neglected tropical diseases. 7(12). e2598–e2598. 26 indexed citations

18.

Zhang, Tianyu, Si-Yang Li, & Eric L. Nuermberger. (2012). Autoluminescent Mycobacterium tuberculosis for Rapid, Real-Time, Non-Invasive Assessment of Drug and Vaccine Efficacy. PLoS ONE. 7(1). e29774–e29774. 67 indexed citations

19.

Zhang, Ming, Si-Yang Li, Ian M. Rosenthal, et al.. (2011). Treatment of Tuberculosis with Rifamycin-containing Regimens in Immune-deficient Mice. American Journal of Respiratory and Critical Care Medicine. 183(9). 1254–1261. 46 indexed citations

20.

Zhang, Tianyu, Si-Yang Li, Kathy N. Williams, Koen Andries, & Eric L. Nuermberger. (2011). Short-Course Chemotherapy with TMC207 and Rifapentine in a Murine Model of Latent Tuberculosis Infection. American Journal of Respiratory and Critical Care Medicine. 184(6). 732–737. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact